X-tosis, Inc.
PrivateLast Round
Grant
Jun 23, 2026
Total Funding Raised
$2.74M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
X-tosis, Inc. is a biotechnology company that develops first-in-class mitochondrial therapeutics targeting VDAC1 oligomerization to treat neurodegenerative diseases such as Alzheimer's and Parkinson's.
Sector
Enterprise Software
Verticals
Biotechnology, Drug Discovery, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
X-tosis, Inc. Comparables
Compare X-tosis, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capacity Bio | 44% | |
| ScandiBio Therapeutics | 42% | |
| MitoSense, Inc. | 34% | |
X-tosis, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 23, 2026 |
Key People
Founding team and executive leadership
X-tosis, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Received $2.74M from The Michael J. Fox Foundation
X-tosis, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about X-tosis, Inc.'s valuation, stock price, and market status.